期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RNA干扰INK4位点反义非编码RNA抑制人肺癌细胞系生长的分子机制 被引量：4

Molecular mechanism of growth inhibition in lung cancer cell line by RNA interference targeting antisense non-coding RNA in the INK4 locus
下载PDF
导出
摘要 目的探讨INK4位点反义非编码RNA(ANRIL)下调对CDKN2B-CDKN2A-ARF基因簇的调控及对人肺癌细胞生长的影响。方法通过RNA干扰下调人肺鳞状细胞癌细胞系H520中ANRIL的表达,实时荧光定量聚合酶链反应检测RNA干扰前后细胞中ANRIL mRNA的表达变化,绘制细胞生长曲线;实时荧光定量聚合酶链反应和蛋白质印迹法检测RNA干扰前后细胞中细胞同期蛋白依赖性激酶抑制剂2B(CDKN2B)、CDKN2A、ARF mRNA和蛋白的表达变化。结果 RNA干扰可显著下调ANRIL mRNA的表达(P<0.05),ANRIL下调能抑制人肺鳞状细胞癌细胞系H520的生长(P<0.05),引起CDKN2B、CDKN2A、ARF mRNA和蛋白的表达升高(P<0.05)。结论 RNA干扰AN-RIL能抑制人肺鳞状细胞癌细胞的生长,ANRIL可能通过调控CDKN2B-CDKN2A-ARF基因簇起作用。 Objective To investigate the regulation of CDKN2B-CDKN2A-ARF gene cluster through down-regulation the antisense non-coding RNA in the INK4 locus（ANRIL）,and its influence on the growth of lung cancer H520 cell line.Methods Expression of ANRIL was knocked down by RNA interference in lung squamous cell carcinoma H520 cell line.mRNA expression of ANRIL was demonstrated by real-time polymerase chain reaction（RT-PCR）,and cell growth curve was made.Protein and mRNA expression of cyclin-dependent kinase inhibitor 2B（CDKN2B）,CDKN2A,ARF gene cluster were demonstrated by Western blot and RT-PCR,respectively.Results RNA interference decreased ANRIL mRNA expression（P〈0.05）,and the decreased ANRIL expression in H520 cell line caused reduction of cell proliferation（P〈0.05）,and increased expression of CDKN2B,CDKN2A,ARF gene cluster（P〈0.05）.Conclusion The RNA interference with ANRIL can inhibit the cell growth of human lung squamous cell cancer,and the ANRIL may work through the regulation of CDKN2B-CDKN2A-ARF gene cluster.
作者 肖颖 王正晖 牛秀珑 申去非
机构地区 武警后勤学院病原生物与免疫学教研室 武警后勤学院组织胚胎与解剖学教研室 武警后勤学院附属医院传染病学教研室 武警后勤学院科研部
出处 《新乡医学院学报》 CAS 2013年第4期259-261,共3页 Journal of Xinxiang Medical University
关键词 肺鳞状细胞癌 INK4位点反义非编码RNA 细胞周期蛋白依赖性激酶抑制剂2B 细胞周期蛋白依赖性激酶抑制剂2A RNA干扰 lung squamous cell carcinoma antisense non-coding RNA in the INK4 locus cyclin-dependent kinase inhibitor 2B cyclin-dependent kinase inhibitor 2A RNA interference
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Lee J T. Epigenetic regulation by long noncoding RNAs [ J ]. Sci- ence,2012,338 (6113 ) : 1435-1439.
  • 2Timofecva M N, Hung R J, Rafnar T, et al. Influence of common genetic variation on lung cancer risk :recta-analysis of 14 900 cases and 29 485 controls [ J ]. Hum Mol Genet, 2012,21 ( 22 ) : 4980- 4995.
  • 3Guilo F,Zhou M M,Walsh M J. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression[ J]. Cancer Res ,2011,71 (16) :5365-5369.
  • 4Toh C K. The changing epidemiology of lung cancer [ J ]. Methods Mol Biol, 2009,472 : 397-411.
  • 5Wiggs J L,Yaspan B L,Hauser M A,et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma [ J ]. PLoS Genct,2012,8 (4) : el 002654.
  • 6Congrains A,Kamide K,Oguro R,et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B [ J ]. Atherosclerosis,2012,220 (2) :449-455.
  • 7Iacobucci I, Sazzini M, Garagnani P, et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia posi- tive acute lymphoblastie leukemia [ J ]. Leuk Res, 2011,35 ( 8 ) : 1052-1059.
  • 8Popov N, Gil J. Epigenetie regulation of the INK4b-ARF-INK4a lo- cus :in sickness and in health [ J 1. Epigenetics, 2010,5 ( 8 ) : 685- 690.
  • 9Gutschner T, Diederichs S. The hallmarks of cancer: a long non- coding RNA point of view [ J ]. RNA Biol, 2012,9 ( 6 ) : 703-719.
  • 10Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 ( INK4B ) tumor suppressor gene [ J ]. Oncogene, 2011,30 (16) : 1956-1962.

同被引文献56

  • 1Roengvoraphoj M, Tsongalis G J, Dragnev K H, et al. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer:focus on epidermal growth factor re- ceptor mutation testing and mutation-positive patients [ J ]. Cancer Treat Rev,2013,39 ( 8 ) : 839-850.
  • 2Lee C K, Brown C, Gralla R J, et al. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival : a meta-ana/ysis[ J]. J Natl Cancer lnst,2013,105(9) :595-605.
  • 3Asami K. Treatment strategy for activating EGFR-mutated non-small cell lung cancer after failure of first-generation EGFR-TKIs [ J ]. Gan To Kagaku Ryoho ,2014 ,41( 5 ) :533-538.
  • 4Zhang L, Zhao G, Hou Y, et aL The experimental study on the treatment of cytokine-induced killer cells combined with EGFR monoclonal antibody against gastric cancer[ J]. Cancer Biother Ra- diopharm ,2014,29 ( 3 ) :99-107.
  • 5Ullrieh E,Koch J,Cerwenka A,et a/. New prospects on the NKG2D/ NKG2DL system for oncolegy[ J ]. Oncoimmunology ,2013 ,2 ( 10 ) : e26097.
  • 6Paschen A, Baingo J, Schadendorf D. Expression of stress ligands of the immunoreceptor NKG2D in melanoma:regulation and clini- cal significance[ J ]. Eur J Cell Bio1,2014,93 (1/2) :49-54.
  • 7Huergo-Zapico L, Acebes-Huerta A, L6pez-Soto A, et al. Molecu- lar bases for the regulation of NKG2D ligands in cancer[ J]. Front Immunol,2014,5 : 106.
  • 8Marcus A, Gowen B G,Thompson T W,et al. Recognition of tumors by the innate immune system and natural killer ceils[ J]. Adv lm- muno1,2014 ,122 :91-128.
  • 9Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment[J]. Nat Rev Cancer,2012,12 (4) : 237-251.
  • 10Boissel N, Rea D, Tieng V, et al. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chro- nic myelogenous leukemia [ J ]. J Immunol, 2006,176 ( 8 ) :5108- 5116.

引证文献4

二级引证文献6

新乡医学院学报
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部